摘要
<jats:title>Key Points</jats:title> <jats:p>The MALT-IPI was built by using 401 patients in the IELSG-19 randomized trial and validated in an independent set (N = 633). This novel disease-specific index efficiently discriminates patient with good, intermediate, and poor outcomes.</jats:p>
- 出版日期2017-9-21
- 单位常州工学院